IGF1 and cancer: Laboratory studies have suggested that 1, 25-dihydroxyvitamin D3, the biologically active form of vitamin D, might play a role in the regulation of several IGF binding proteins including the major binding protein IGFBP-3, indicating that some of the cancer promoting effects of IGF-1 may be modified by vitamin D [39]–[41].